An oil processing facility at Abqaiq and the nearby Khurais oil field was attacked on Saturday.Marketsread more
"There is reason to believe that we know the culprit," Trump said in a post on Twitter.Politicsread more
Brent crude surged by as much as 19.5% to reach $71.95 per barrel on Monday, the biggest intra-day jump since the Gulf War in 1991.Oilread more
The strike, depending on its length, could easily cost GM hundreds of millions of dollars. The last time the union declared a strike at GM was in 2007.Autosread more
Saudi Aramco has 35-40 days of supply to meet contractual obligations, a source close to the matter told CNBC.Energyread more
The trucking industry is worth hundreds of billions of dollars per year. Uber is going after this market with Uber Freight, an online platform that matches truckers with...Technologyread more
OxyContin maker Purdue Pharma filed for Chapter 11 bankruptcy protection on Sunday.Health and Scienceread more
Saudi Arabia on Saturday shut down half its oil production after a series of drone strikes hit the world's largest oil processing facility in an attack claimed by Yemen's...Futures & Commoditiesread more
U.S. stock futures sank amid fears that a surge in oil prices following an attack in Saudi Arabia could slow down global economic growth.Marketsread more
The recommendations include changing corporate reporting structures, creating a new safety group, and changing the cockpits of future planes to accommodate new pilots with...Aerospace & Defenseread more
The state would become the second in the country, behind Michigan, to ban the sale of fruit flavored e-cigarettes, which are popular with teenagers.Health and Scienceread more
Shares of Canadian pot grower Tilray fell sharply on Monday, erasing gains from a wild week that captivated investors everywhere.
The stock tanked 19.1 percent. Last week, Tilray's stock posted a 12.8 percent gain after some sharp moves.
Tilray's stock surged more than 77 percent in the first three trading days of last week but then dropped 47.9 percent to close out the week. The initial jump sent Tilray's market cap to nearly $20 billion before ending the week around $10 billion.
Two catalysts drove Tilray's initial surge last week. First, Tilray announced on Tuesday the Drug Enforcement Administration approved it to import marijuana to the U.S. for medical research. CEO Brendan Kennedy later told CNBC's that global pharmaceuticals must think about partnering with cannabis producers as a "hedge" against the space.
"Cannabis is a substitute for prescription painkillers, prescription opioids, and so if you're an investor in a pharmaceutical company or you're a pharmaceutical company, you have to hedge the offset from cannabis substitution," Kennedy said.
Tilray's meteoric rise also bolstered other marijuana stocks. The ETFMG Alternative Harvest ETF (MJ), which tracks marijuana shares, rose more than 10 percent last week. Shares of Toronto-listed Cronos Group, meanwhile, gained 18.3 percent, while Aurora Cannabis jumped 38 percent.